Guerbet Group (GBT-PA, $62.25 EU). An Inexpensive Transformational Acquisition.

All numbers and estimates expressed in Euro, unless otherwise specified.

http://www.guerbet.com/en/our-group/news/news-2012/news/article2/acquisition.html

http://www.fiercemedicaldevices.com/story/mallinckrodt-sell-contrast-business-french-imaging-player-guerbet-270m/2015-07-28

Guerbet Group has roughly 12.2 million shares outstanding.
The 2014 trailing EV is $820 million Euro.
2014 EBITDA was expressed at $67.7 million Euro, which is an EBITDA margin of 16.5%.
2014 trailing EV/EBITDA ratio = 12.1X

Assuming that the $47 million of purchased earnings flows through to Guerbet, this represents earnings accretion of almost $3.39 Euro per share.

Proforma 2016 EBITDA could touch $130 million Euro.
The 2016 enterprise value, on a proforma basis, could be $1,040 billion Euro.
My estimate of the 2016 EV/EBITDA ratio, pro-forma, is 8.0X.

Guerbet Group is funding the entire purchase through lines of credit and loans, rather than the issuance of equity. This conventional purchase arrangement looks to be paid off quite quickly, given the cash generating potential of the combined assets.